Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Copenhagen - Delayed Quote DKK

Genmab A/S (GMAB.CO)

Compare
1,291.50
-1.50
(-0.12%)
At close: 4:59:53 PM GMT+2
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
21,526,000
21,526,000
16,474,000
14,505,000
8,417,000
Cost of Revenue
985,000
985,000
226,000
--
--
Gross Profit
20,541,000
20,541,000
16,248,000
14,505,000
8,417,000
Operating Expense
13,538,000
13,538,000
10,927,000
8,238,000
5,464,000
Operating Income
7,003,000
7,003,000
5,321,000
6,267,000
2,953,000
Net Non Operating Interest Income Expense
875,000
875,000
901,000
285,000
184,000
Other Income Expense
1,286,000
1,286,000
-596,000
393,000
781,000
Pretax Income
9,164,000
9,164,000
5,637,000
6,945,000
3,918,000
Tax Provision
1,320,000
1,320,000
1,285,000
1,493,000
961,000
Net Income Common Stockholders
7,844,000
7,844,000
4,352,000
5,452,000
2,957,000
Diluted NI Available to Com Stockholders
7,844,000
7,844,000
4,352,000
5,452,000
2,957,000
Basic EPS
122.21
--
66.64
83.38
46.00
Diluted EPS
121.36
--
66.02
82.59
45.54
Basic Average Shares
64,186.65
--
65,309.74
65,387.30
65,634.30
Diluted Average Shares
64,632.94
--
65,914.71
66,009.60
66,045.75
Total Operating Income as Reported
6,703,000
6,703,000
5,321,000
6,267,000
2,953,000
Total Expenses
14,523,000
14,523,000
11,153,000
8,238,000
5,464,000
Net Income from Continuing & Discontinued Operation
7,844,000
7,844,000
4,352,000
5,452,000
2,957,000
Normalized Income
6,743,237.89
6,743,237.89
4,812,136.95
5,143,485.10
2,367,562.28
Interest Income
995,000
995,000
971,000
324,000
197,000
Interest Expense
120,000
120,000
70,000
39,000
13,000
Net Interest Income
875,000
875,000
901,000
285,000
184,000
EBIT
9,284,000
9,284,000
5,707,000
6,984,000
3,931,000
EBITDA
9,697,000
9,697,000
6,002,000
7,346,000
4,179,000
Reconciled Cost of Revenue
985,000
985,000
226,000
--
--
Reconciled Depreciation
413,000
413,000
295,000
362,000
248,000
Net Income from Continuing Operation Net Minority Interest
7,844,000
7,844,000
4,352,000
5,452,000
2,957,000
Total Unusual Items Excluding Goodwill
1,286,000
1,286,000
-596,000
393,000
781,000
Total Unusual Items
1,286,000
1,286,000
-596,000
393,000
781,000
Normalized EBITDA
8,411,000
8,411,000
6,598,000
6,953,000
3,398,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
185,237.89
185,237.89
-135,863.05
84,485.10
191,562.28
12/31/2021 - 10/20/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BAVA.CO Bavarian Nordic A/S
151.65
+0.43%
 
ZEAL.CO Zealand Pharma A/S
424.50
-4.61%
 
GUBRA.CO Gubra A/S
356.00
-4.30%
 
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
 
EVAX Evaxion Biotech A/S
1.3100
-4.38%
 
ASND Ascendis Pharma A/S
158.15
+2.75%
 
YMAB Y-mAbs Therapeutics, Inc.
4.5400
-15.14%
 
FLUO.ST FluoGuide A/S
39.00
+0.52%
 
BVNRY Bavarian Nordic A/S
7.62
+1.87%
 
SANION.ST Saniona AB (publ)
6.15
-6.11%